GAMEC - a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours (vol 97, pg 1188, 2007)

被引：3
|
作者：
Shamash, J.
Powles, T.
Ansell, W.
Berney, D.
Stebbing, J.
Mutsvangwa, K.
Wilson, P.
Asterling, S.
Liu, S.
Wyatt, P.
Joel, S. P.
Oliver, R. T. D.
机构：
来源：
BRITISH JOURNAL OF CANCER | 2007年 / 97卷 / 08期
关键词：
D O I：
10.1038/sj.bjc.6604041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Correction to: British Journal of Cancer (2007) 97, 308–314. doi: 10.1038/6603865 Owing to an author's error, the name of the fourth author of the above paper, Dan Berney, was omitted when originally published in Volume 97, Number 3. We are now happy to correct this mistake; the full, correct authorship is now listed above.
引用
收藏
页码：1188 / 1188
页数：1
相关论文
共 31 条
  • [1] GAMEC - a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
    Shamash, J.
    Powles, T.
    Ansell, W.
    Stebbing, J.
    Mutsvangwa, K.
    Wilson, P.
    Asterling, S.
    Liu, S.
    Wyatt, P.
    Joel, S. P.
    Oliver, R. T. D.
    BRITISH JOURNAL OF CANCER, 2007, 97 (03) : 308 - 314
  • [2] GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
    J Shamash
    T Powles
    W Ansell
    J Stebbing
    K Mutsvangwa
    P Wilson
    S Asterling
    S Liu
    P Wyatt
    S P Joel
    R T D Oliver
    British Journal of Cancer, 2007, 97 : 308 - 314
  • [3] Erratum: GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
    J Shamash
    T Powles
    W Ansell
    D Berney
    J Stebbing
    K Mutsvangwa
    P Wilson
    S Asterling
    S Liu
    P Wyatt
    S P Joel
    R T D Oliver
    British Journal of Cancer, 2007, 97 : 1188 - 1188
  • [4] GAMEC - A novel protocol for IGCCCG poor prognosis and relapsing germ cell tumours
    Shamash, J
    Oliver, RTD
    Steele, JPC
    Ansell, W
    Millard, L
    GERM CELL TUMOURS V, 2002, : 240 - 241
  • [5] Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy
    Shamash, Jonathan
    Mee, Matthew
    Sarker, Shah-Jalal
    Wilson, Peter
    Ansell, Wendy
    Greenwood, Michelle
    Berney, Dan
    Alifrangis, Constantine
    BJU INTERNATIONAL, 2020, 125 (06) : 843 - 852
  • [6] GAMEC - A novel protocol for patients with germ cell tumours (GCT) relapsing following conventional treatment or with de novo IGCCCG poor prognosis.
    Shamash, J
    Joel, SP
    Irwin, HL
    Steele, JP
    Asterling, S
    Oliver, RTD
    BRITISH JOURNAL OF CANCER, 1999, 80 : 110 - 110
  • [7] Is there a role for short intensive therapy without stem cell support in relapsed germ cell tumours? A single centre experience of GAMEC chemotherapy
    Hockings, Helen
    Wilson, Peter
    Mazhar, Danish
    Chowdhury, Simon
    Mutsvangwa, Katherine
    Shamash, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] GAMEC Chemotherapy for Untreated and Relapsed Germ Cell Tumours: 15 Years of Experience with a Dose Intense Regimen at St Bartholomew's Hospital
    Mee, M.
    Hall, P.
    Wilson, P.
    Shamash, J.
    CLINICAL ONCOLOGY, 2017, 29 (03) : E89 - E89
  • [9] Efficacy of Gemcitabine, Paclitaxel, and Oxaliplatin Protocol in the Treatment of Relapsed or Refractory Germ Cell Tumours
    Aykan, Musa Baris
    Yildiran, Gul Sema
    Akcan, Ece
    Acar, Ramazan
    Erturk, Ismail
    Karadurmus, Nuri
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (07): : 880 - 884
  • [10] High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours
    El-Helw, Loale M.
    Naik, Jay D.
    Chester, John D.
    Joffe, Johnathan K.
    Selby, Peter J.
    Coleman, Robert E.
    BJU INTERNATIONAL, 2006, 98 (03) : 519 - 525
1234